Cite
HARVARD Citation
Fowler, A. et al. (2017). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well‐Controlled Asthma. Journal of clinical pharmacology. pp. 1444-1453. [Online].